Dannielle Appelhans, CEO & President at Rubius Therapeutics, holds 20.00K shares in Generation Bio (Ticker: GBIO), holds 0.00 shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Dannielle Appelhans Bought ― shares of Generation Bio on Dec 11, 2023 for an estimated value of 14.34K.
What is the percentage of profitable transactions made by Dannielle Appelhans?
The percentage of profitable transactions made by Dannielle Appelhans is 100%.
What is the average return per transaction made by Dannielle Appelhans?
The average return per transaction made by Dannielle Appelhans is 28.60%.
What stocks does Dannielle Appelhans hold?
Dannielle Appelhans holds: RUBY, GBIO stocks.
What was Dannielle Appelhans’s latest transaction?
Dannielle Appelhans latest transaction was an Informative Buy of $14.34K.
What was Dannielle Appelhans's most profitable transaction?
Dannielle Appelhans’s most profitable transaction was an Informative Buy of GBIO stock on December 6, 2023. The return on the trade was 33.10%.
What is Dannielle Appelhans's role in Rubius Therapeutics?
Dannielle Appelhans's role in Rubius Therapeutics is CEO & President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.